ProVise Management Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-817
Closed -$248K 347
2023
Q2
$248K Sell
817
-483
-37% -$134K 0.02% 304
2023
Q1
$343K Hold
1,300
0.03% 265
2022
Q4
$312K Hold
1,300
0.03% 253
2022
Q3
$239K Buy
+1,300
New +$259K 0.03% 270
2022
Q2
Sell
-1,165
Closed -$292K 338
2022
Q1
$292K Hold
1,165
0.03% 290
2021
Q4
$299K Hold
1,165
0.03% 306
2021
Q3
$283K Hold
1,165
0.03% 300
2021
Q2
$241K Hold
1,165
0.02% 336
2021
Q1
$219K Buy
+1,165
New +$205K 0.02% 324
2019
Q3
Sell
-1,615
Closed -$218K 316
2019
Q2
$218K Hold
1,615
0.03% 283
2019
Q1
$211K Sell
1,615
-695
-30% -$93.3K 0.03% 283
2018
Q4
$287K Buy
+2,310
New +$310K 0.05% 234

Other funds holding HCA

ProVise Management Group's HCA Position: Q3 2023 in Review

ProVise Management Group sold out of HCA Healthcare (HCA) in Q3 2023, closing a stake of 817 shares — an estimated $248K sold.

ProVise Management Group first reported a position in HCA in Q4 2018 and held it in 12 quarters. The position peaked at $343K in Q1 2023. 1,000 funds tracked by Wall St. Rank hold HCA as of Q3 2023.

  • ProVise Management Group reported no remaining HCA Healthcare position as of Q3 2023 after selling out during the quarter.
  • ProVise Management Group sold 817 HCA Healthcare shares in Q3 2023, an estimated $248K.
  • ProVise Management Group first reported a position in HCA Healthcare in Q4 2018 and held it in 12 quarters.
  • ProVise Management Group's HCA Healthcare position peaked at $343K in Q1 2023.
  • 1,000 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2023.

Based on ProVise Management Group's 13F filing for Q3 2023, filed 8 Nov 2023.